# EDGAR Filing Document

**Accession Number:** 0001471570
**File Stem:** 0001127602-23-001257
**Filing Date:** 2023-1
**Character Count:** 6573
**Document Hash:** 0799e20e9220319638bcd7aa5ef70cf5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001127602-23-001257.hdr.sgml**: 20230111

**ACCESSION NUMBER**: 0001127602-23-001257

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230109

**FILED AS OF DATE**: 20230111

**DATE AS OF CHANGE**: 20230111

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Pike Thomas
- **CENTRAL INDEX KEY:** 0001471570

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-11353
- **FILM NUMBER:** 23522615

**MAIL ADDRESS:**
- **STREET 1:** C/O ACCENTURE
- **STREET 2:** 161 N. CLARK STREET, 23RD FLOOR
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60601
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** LABORATORY CORP OF AMERICA HOLDINGS
- **CENTRAL INDEX KEY:** 0000920148
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MEDICAL LABORATORIES [8071]
- **IRS NUMBER:** 133757370
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 358 S MAIN ST
- **CITY:** BURLINGTON
- **STATE:** NC
- **ZIP:** 27215
- **BUSINESS PHONE:** 3362291127

**MAIL ADDRESS:**
- **STREET 1:** 358 S MAIN ST
- **CITY:** BURLINGTON
- **STATE:** NC
- **ZIP:** 27215

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** NATIONAL HEALTH LABORATORIES HOLDINGS INC
- **DATE OF NAME CHANGE:** 19940314

## Ex-24

```

EXHIBIT 24

                                   POWER OF ATTORNEY
                                   -----------------

KNOWN ALL MEN BY THESE PRESENTS, that the undersigned hereby constitutes
and appoints Sandra D. van der Vaart attorney-in-fact and agent, in
connection with the filing for the undersigned on Form 3, Form 4, and Form 5
under the Securities Act of 1934, as amended, including, without limiting
the generality of the foregoing, to sign the Form 3, Form 4, and Form 5 with
respect to the undersigned's holding of and transactions in securities
issued by Laboratory Corporation of America Holdings, in the name and on
behalf of the undersigned as an officer of Laboratory Corporation of America
Holdings, and any amendments to the Form 3, Form 4, or Form 5 and any
instrument, contract, document or other writing, of or in connection with the
Form 3, Form 4, and Form 5 or amendments thereto, and to file the same, with
all exhibits thereto, and other documents in connection therewith, including
this power of attorney, with the Securities and Exchange Commission and any
applicable securities exchange or securities self-regulatory body, granting
unto said attorney-in-fact and agents, each acting alone, full power and
authority to do and perform each and every act and thing requisite and
necessary to be done in and about the premises, as fully to all intents and
purposes as he might or could do in person, hereby ratifying and confirming
all that said attorney-in-fact and agents, each acting alone, or her
substitute or substitutes, may lawfully do or cause to be done by virtue
hereof.  This power of attorney shall become effective immediately, and
shall remain in full force and effect until the undersigned is no longer
required to file Forms 3, 4 and 5, with respect to the undersigned's
holdings of and transactions in securities issued by Laboratory Corporation
of America Holdings, unless earlier revoked by the undersigned in a signed
writing delivered to the foregoing attorney-in-fact.

IN WITNESS WHEREOF, the undersigned has signed these presents this 10th day
of January, 2023.

                                   /s/ Thomas Pike
                                   ----------------------
                                   Thomas Pike

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Pike Thomas<br><sub>(Last) (First) (Middle)</sub><br>531<br>SOUTH SPRING STREET<br><sub>(Street)</sub><br>BURLINGTON, NC 27215<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>LABORATORY CORP OF AMERICA HOLDINGS [ LH ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2023-01-09 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_Pres & CEO Clinical Business_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |

---

**Remarks:**
Exhibit 24 - Power of Attorney

**Signature:** /s/ Sandra D. van der Vaart, Attorney-in-Fact for Thomas Pike  
**Date:** 2023-01-11

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**